Monday, September 27, 2004

Pfizer to contest Chinese action on Viagra patent


Pfizer Inc. appealed on Sept. 28 China's revocation of its Viagra patent in a case that may test the nation's commitment to stronger protection for intellectual property rights.

The appeal of the July decision by China's State Intellectual Property Office was filed with the Beijing First Intermediate People's Court, Wang Xunbiao, public relations manager in Beijing for the New York-based company, said in a telephone interview.


Post a Comment

<< Home